Evolent Health (EVH) has issued an announcement.
Evolent Health, Inc. has announced a strategic move to enhance its offerings by acquiring assets and a perpetual license from Machinify for $25 million, with an additional earn-out potential of $7 million. The completion of this deal, expected by the third quarter of 2024, is subject to standard closing conditions. However, the company cautions that these forward-looking statements are not guarantees of future performance, and actual results may differ. For a detailed understanding of the risks involved, the company advises consulting its recent filings with the U.S. Securities and Exchange Commission.
For an in-depth examination of EVH stock, go to TipRanks’ Stock Analysis page.
